Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Cinemark Holdings
CNK
$3.25B
| $2.87M | ﹤0.01% |
248,400
+32,600
| +15% | +$377K |
|
1502
ATI
ATI
$10.5B
| $2.87M | ﹤0.01% |
281,500
+37,000
| +15% | +$377K |
|
1503
Delek US
DK
$1.68B
| $2.86M | ﹤0.01% |
164,019
+19,700
| +14% | +$343K |
|
1504
Gentherm
THRM
$1.06B
| $2.85M | ﹤0.01% |
73,300
+10,000
| +16% | +$389K |
|
1505
Schneider National
SNDR
$4.18B
| $2.85M | ﹤0.01% |
115,500
+15,100
| +15% | +$372K |
|
1506
Range Resources
RRC
$8.41B
| $2.84M | ﹤0.01% |
505,100
+90,600
| +22% | +$510K |
|
1507
Twist Bioscience
TWST
$1.53B
| $2.84M | ﹤0.01% |
62,700
+8,100
| +15% | +$367K |
|
1508
Trupanion
TRUP
$1.87B
| $2.83M | ﹤0.01% |
66,310
+8,700
| +15% | +$371K |
|
|
VGR
1509
DELISTED
Vector Group Ltd.
VGR
| $2.82M | ﹤0.01% |
395,467
+72,192
| +22% | +$515K |
|
1510
Penske Automotive Group
PAG
$11.9B
| $2.81M | ﹤0.01% |
72,700
+2,000
| +3% | +$77.4K |
|
1511
CBIZ
CBZ
$3.01B
| $2.81M | ﹤0.01% |
117,300
+16,100
| +16% | +$386K |
|
|
ICPT
1512
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.81M | ﹤0.01% |
58,700
+7,900
| +16% | +$378K |
|
|
NAV
1513
DELISTED
Navistar International
NAV
| $2.81M | ﹤0.01% |
99,700
+13,200
| +15% | +$372K |
|
1514
Heron Therapeutics
HRTX
$193M
| $2.81M | ﹤0.01% |
191,000
+25,100
| +15% | +$369K |
|
1515
SITE Centers
SITC
$463M
| $2.8M | ﹤0.01% |
443,614
+58,192
| +15% | +$368K |
|
1516
Hilltop Holdings
HTH
$2.18B
| $2.8M | ﹤0.01% |
151,800
+11,200
| +8% | +$207K |
|
1517
Adverum Biotechnologies
ADVM
$63.4M
| $2.8M | ﹤0.01% |
13,400
+1,900
| +17% | +$397K |
|
1518
Materion
MTRN
$2.31B
| $2.8M | ﹤0.01% |
45,500
+5,900
| +15% | +$363K |
|
|
RVNC
1519
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.8M | ﹤0.01% |
114,450
+24,400
| +27% | +$596K |
|
|
OPI
1520
Office Properties Income Trust
OPI
$40.8M
| $2.79M | ﹤0.01% |
107,533
+14,000
| +15% | +$364K |
|
1521
La-Z-Boy
LZB
$1.39B
| $2.78M | ﹤0.01% |
102,900
+12,900
| +14% | +$349K |
|
1522
Supernus Pharmaceuticals
SUPN
$2.55B
| $2.78M | ﹤0.01% |
117,100
+15,400
| +15% | +$366K |
|
|
PDCE
1523
DELISTED
PDC Energy, Inc.
PDCE
| $2.78M | ﹤0.01% |
223,514
+29,900
| +15% | +$372K |
|
1524
Champion Homes, Inc.
SKY
$4.22B
| $2.77M | ﹤0.01% |
113,900
+15,000
| +15% | +$365K |
|
1525
Gray Television
GTN
$598M
| $2.77M | ﹤0.01% |
198,600
+17,000
| +9% | +$237K |
|